Pfizer PFE faces a number of structural headwinds, ranging from patent expirations and declining COVID-19 revenues to pricing pressure, intense competition and the need to replenish its pipeline.

Pfizer on Tuesday reported fourth-quarter earnings and revenue that beat estimates as sales of the company's Covid products topped expectations and its broad cost-cutting efforts took hold. The ...

Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year outlook as its Covid vaccine and antiviral pill Paxlovid helped boost sales. It ...

Updated COVID-19 vaccines are here for the 2026-2027 season. An immunologist explains what’s changed, who’s eligible, and when to get one.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The new vaccines are designed to protect against the influenza A (H3N2) subclade K virus of the flu that spread during last ...

Shionogi’s Xocova campaign has to teach people what post-exposure prevention is, when to act and why a conversation about ...

Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...

It might still feel like summer — but it’s time to start thinking about respiratory virus season. Despite inconsistent — and sometimes inaccurate — vaccine recommendations during President Donald ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...